Glatiramer acetate attenuates the pro-migratory profile of adhesion molecules on various immune cell subsets in multiple sclerosis

Therapeutic manipulation of natural killer (NK) T cells in autoimmunity: are we close to reality?

(2012) Y. Simoni et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Characterization of natural killer cells in paired CSF and blood samples during neuroinflammation

(2012) Isabell Hamann et al.   JOURNAL OF NEUROIMMUNOLOGY

Markedly Elevated Soluble Intercellular Adhesion Molecule 1, Soluble Vascular Cell Adhesion Molecule 1 Levels, and Blood-Brain Barrier Breakdown in Neuromyelitis Optica

(2011) Akiyuki Uzawa   ARCHIVES OF NEUROLOGY

The increasing incidence and prevalence of female multiple sclerosis—A critical analysis of potential environmental factors

(2011) Johann Sellner et al.   AUTOIMMUNITY REVIEWS

Primed status of transitional B cells associated with their presence in the cerebrospinal fluid in early phases of multiple sclerosis

(2011) Catalina Lee-Chang et al.   CLINICAL IMMUNOLOGY

Glatiramer Acetate in the Treatment of Multiple Sclerosis

(2011) Patrice H. Lalive et al.   CNS DRUGS

B cells undergo unique compartmentalized redistribution in multiple sclerosis

(2011) Jürgen Haas et al.   JOURNAL OF AUTOIMMUNITY

Th17 lymphocytes traffic to the central nervous system independently of α4 integrin expression during EAE

(2011) Veit Rothhammer et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Recent insights into the mechanism of action of glatiramer acetate

(2011) Mrinalini Kala et al.   JOURNAL OF NEUROIMMUNOLOGY

Natalizumab therapy decreases surface expression of both VLA-heterodimer subunits on peripheral blood mononuclear cells

(2011) Andrea Harrer et al.   JOURNAL OF NEUROIMMUNOLOGY

Biomarkers of disease activity in multiple sclerosis

(2011) Jerome J. Graber et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Soluble and cell surface ICAM-1 as markers for disease activity in multiple sclerosis

(2010) J. Kraus et al.   ACTA NEUROLOGICA SCANDINAVICA

Inflammation, demyelination, and degeneration — Recent insights from MS pathology

(2010) Christine Stadelmann et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Glatiramer acetate for treatment of MS: Regulatory B cells join the cast of players

(2010) Luc Van Kaer   EXPERIMENTAL NEUROLOGY

Natalizumab treatment reduces endothelial activity in MS patients

(2010) Alban Millonig et al.   JOURNAL OF NEUROIMMUNOLOGY

Adhesion molecules are promising candidates to establish surrogate markers for natalizumab treatment

(2010) P Wipfler et al.   Multiple Sclerosis Journal

Leukocyte integrins and their ligand interactions

(2009) Young-Min Hyun et al.   IMMUNOLOGIC RESEARCH

Pathophysiology of multiple sclerosis

(2009) Thomas Korn   JOURNAL OF NEUROLOGY

Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS

(2009) F. Sellebjerg et al.   NEUROLOGY

Memory and naïve B-cell subsets in patients with multiple sclerosis

(2009) Masaaki Niino et al.   NEUROSCIENCE LETTERS

Cytometric profiling in multiple sclerosis uncovers patient population structure and a reduction of CD8low cells

(2008) Philip L. De Jager et al.   BRAIN

Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease [REGARD] study): a multicentre, randomised, parallel, open-label trial

(2008) Daniel D Mikol et al.   LANCET NEUROLOGY

Cerebrospinal Fluid B Cells Correlate with Early Brain Inflammation in Multiple Sclerosis

(2008) Bettina Kuenz et al.   PLoS One